RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Rgenta Therapeutics

Rgenta Therapeutics

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.

Latest funding

$52M Series A ·

Led by AstraZeneca · Source: fundraisingfox.com

Latest round on record: Series B+, November 2026, amount undisclosed.

All 3 rounds ↓
Website: rgentatx.com.
X: @RgentaTx · 40 followers.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Medical, Oncology, Pharmaceutical.
Stage: Series B+.
Based in: Cambridge, United States.
Founded: 2019.
Last round: Nov 3, 2026 · 13 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

X account@RgentaTx · created Jan 29, 2020 (6 years old) · 40 followers
Website registeredApr 4, 2018 (8 years old)
TIMELINE · MONEY RAISED

Rgenta Therapeutics | 1147 days from website to first raise on record

@RgentaTx·Raised $52M in 1 sourced round·2 signals before the first raise
$13M$26M$39M$52MAPRJUNAUGOCTDECFEBAPRJUN$52M||WEBSITE CREATED · APR 4, 2018||X ACCOUNT CREATED @RGENTATX · JAN 29, 2020Seed · May 25, 2021SEED · MAY '21$52M Series A · Nov 29, 2022$52M A · NOV '22Series B+ · Nov 3, 2026B+ · NOV '26

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+undisclosed—sec.gov
Series A$52MAAstraZenecafundraisingfox.com
Seedundisclosed—biospace.com

Timeline

  1. X account created
  2. Website created

Founders and team

Investors

Companies like Rgenta Therapeutics

Other companies backed by AstraZeneca

AstraZeneca portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/rgenta-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy